Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on October 16th, 2025 | 07:20 CEST
Investors take note: BioNxt Solutions builds on blockbusters from Novo Nordisk and Merck - and has another ace up its sleeve in oncology
In the biotech sector, a single technology can often determine success or failure. Canadian-German company BioNxt Solutions is taking a different approach, relying on three pillars, each targeting major markets and advancing established blockbusters from leading pharmaceutical companies. October has already brought decisive progress, from accelerated patent protection to concrete milestones in development. These concentrated positive signals show that BioNxt Solutions not only has a promising concept, but also the strategy and operational strength to turn it into value. A closer analysis is worthwhile.
Read
Commented by Armin Schulz on October 15th, 2025 | 07:15 CEST
How your portfolio can benefit from the green energy boom with Nordex, RE Royalties, and JinkoSolar
Winners despite turbulent times: As the global energy transition gains momentum, a future market worth billions is emerging. Ever-larger wind turbines, more cost-effective solar modules, and an explosive growth in demand for green electricity are driving the revolution. Innovative companies that produce, finance, or supply clean energy are at the heart of this boom. Three promising players have already positioned themselves and could benefit directly: Nordex, RE Royalties, and JinkoSolar.
Read
Commented by Armin Schulz on October 15th, 2025 | 07:00 CEST
Volkswagen in a tight spot: Why European Lithium and Standard Lithium are now the more valuable players
The global electric vehicle revolution is facing its biggest test yet. China's looming export restrictions on critical battery raw materials threaten to destabilize Western manufacturers' supply chains from 2025 and increase production costs. But it is precisely these geopolitical tensions that are catapulting independent lithium producers into the spotlight. While established giants are fighting for their security of supply, agile players are benefiting from this power vacuum. The strategic maneuvers of Volkswagen, European Lithium, and Standard Lithium reveal who the real winners of this upheaval will be.
Read
Commented by Armin Schulz on October 14th, 2025 | 07:25 CEST
China closes the door – NEO Battery Materials opens a window to profits in the drone market
From November 2025, China will tighten export controls. The export of high-performance batteries and related materials will become significantly more difficult. This political decision is turning the global supply chain for electric mobility and high-tech upside down. While established players outside China struggle, a small Canadian company is catapulting itself into a unique position. NEO Battery Materials has positioned itself in the right place at precisely the right time. For investors, this creates a rare opportunity to profit from a geopolitical turning point.
Read
Commented by Armin Schulz on October 14th, 2025 | 07:00 CEST
Why RENK Group needs Antimony Resources just as much as the largest US defense contractor, RTX
The global defense industry is facing a fundamental supply crisis. Antimony, a largely overlooked metal that is indispensable for high-performance electronics, armor-piercing alloys, and flame-resistant propulsion systems, is becoming a key strategic factor. Prices are skyrocketing, and massive supply bottlenecks are emerging. This shortage is hitting defense giants and suppliers hard, forcing them to radically rethink their procurement strategy. Today, we take a closer look at the current situation of the RENK Group, the explorer Antimony Resources, and the largest US defense contractor RTX.
Read
Commented by Armin Schulz on October 13th, 2025 | 07:20 CEST
The beneficiaries of the raw materials crisis: How BYD is circumventing the problem, and how Power Metallic Mines and Albemarle are profiting
The global energy transition is fueling an unprecedented hunger for strategic metals. However, China's recent tightening of export controls on critical raw materials has triggered a global supply alert and sent markets into turmoil. This geopolitical turning point is forcing the West to radically rethink its approach and is fueling a fierce race for secure supply chains. In this volatile environment, smart players are repositioning themselves along the entire value chain. Who are the winners in this new reality? The strategies of BYD, Power Metallic Mines, and Albemarle provide decisive answers.
Read
Commented by Armin Schulz on October 13th, 2025 | 07:10 CEST
Why smart investors should be looking at Gerresheimer, Desert Gold, and Puma NOW!
The true potential of a portfolio is revealed not in calm markets, but in turbulent ones. While the masses are driven by price fluctuations, savvy investors recognize opportunities in companies that have recently underperformed. The key lies in a targeted analysis of resilient niche players, commodity experts with unique access, and global consumer brands that are on the verge of a turnaround. This strategic positioning often makes the difference between average and exceptional returns. Three promising candidates that currently embody this profile are Gerresheimer, Desert Gold, and Puma.
Read
Commented by Armin Schulz on October 10th, 2025 | 07:15 CEST
From food waste to profit: How Nestlé, Planethic Group, and HelloFresh are capitalizing on the latest megatrends
The food industry is currently undergoing what may be the most lucrative revolution in its history. Driven by groundbreaking technologies, from 2D printing for food to the hype surrounding plant-based proteins, and the global drive to curb food waste, entirely new markets are emerging. By keeping an eye on the companies driving these megatrends, you can identify the major growth opportunities of the future at an early stage. Today, we take a close look at the strategies of Nestlé, Planethic Group, and HelloFresh and ask ourselves: Which stocks really have what it takes to succeed?
Read
Commented by Armin Schulz on October 10th, 2025 | 07:00 CEST
Drone boom vs. pilot strike: What you need to know about DroneShield, Volatus Aerospace, and Lufthansa
As the global drone market expands at double-digit growth rates, unprecedented opportunities are emerging above and beyond the clouds. Innovative technologies are driving not only military but also civilian applications into previously untapped economic areas. This high-flying growth stands in sharp contrast to the challenges facing traditional aviation, which is being hit by operational difficulties. Three companies - DroneShield, Volatus Aerospace, and Lufthansa - embody these contrasting realities, highlighting both the lucrative paths of the future and the risks inherent in the sector.
Read
Commented by Armin Schulz on October 9th, 2025 | 07:40 CEST
AI paves the way to the next blockbuster: The current situation at Novo Nordisk, NetraMark Holdings and Evotec
The pharmaceutical industry is at a historic turning point. Artificial intelligence is breaking through the lengthy and costly development cycles that have characterized the sector for decades. This technological quantum leap is revolutionizing drug discovery and promises to transform healthcare from the ground up. The first companies to master this AI revolution will be the biggest winners in a billion-dollar market. We therefore take a look at three companies that are already using AI today: the Danish pharmaceutical giant Novo Nordisk, AI specialist NetraMark Holdings for clinical studies, and the German research service provider Evotec, and analyze their current situation.
Read